比较NICHD小组建议与新生儿脓毒症风险计算器在暴露于母体绒毛膜羊膜炎的足月新生儿中的应用
本研究为回顾性病历审查,纳入2018—2020年出生、胎龄≥37周且母亲患绒毛膜羊膜炎的新生儿101例,均接受抗生素治疗。用SRC评估仅16/101(15.84%)需治疗,用NICHD算法评估71/101(70.30%)需治疗,两法仅44/101(43.56%)评估一致。NICHD治疗组胎盘病理绒毛膜羊膜炎发生率更高(94.37% vs 75.00%,p=0.015),SRC治疗组1分钟和5分钟Apgar评分更低(8.21 vs 6.63,p=0.006;8.69 vs 8.00,p=0.019),入院时需补氧比例更高(62.50% vs 21.13%,p<0.001)。两种算法均减少抗生素暴露,但需抗生素的新生儿数量不同。
要点
- 在101例接受抗生素治疗的暴露于母体绒毛膜羊膜炎的足月新生儿中,SRC评估仅16/101(15.84%)需治疗,NICHD算法评估71/101(70.30%)需治疗。
- 两种算法在治疗或仅观察的评估上仅44/101(43.56%)一致,差异显著。
- NICHD治疗组胎盘病理确诊绒毛膜羊膜炎比例高于SRC治疗组(94.37% vs 75.00%,p=0.015)。
- SRC治疗组1分钟Apgar评分(8.21 vs 6.63,p=0.006)和5分钟Apgar评分(8.69 vs 8.00,p=0.019)均更低,入院时需补氧比例更高(62.50% vs 21.13%,p<0.001)。
- 通气支持和较低Apgar评分与更高的抗生素使用概率相关。
适用人群与场景
- 2018—2020年出生、胎龄≥37周、母亲患绒毛膜羊膜炎且接受抗生素治疗的新生儿。
研究设计与关键结果
- 研究类型:回顾性病历审查;样本量:101例新生儿;人群:胎龄≥37周、母亲患绒毛膜羊膜炎的新生儿。
- SRC评估需抗生素:16/101(15.84%);NICHD算法评估需抗生素:71/101(70.30%);两种算法评估一致:44/101(43.56%)。
- NICHD治疗组胎盘病理绒毛膜羊膜炎发生率94.37% vs SRC治疗组75.00%,p=0.015。
- SRC治疗组1分钟Apgar评分8.21 vs 6.63,p=0.006;5分钟Apgar评分8.69 vs 8.00,p=0.019。
- SRC治疗组入院时需补氧比例62.50% vs 21.13%,p<0.001。
证据类型、等级与局限
- 证据类型:回顾性病历审查。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,SRC和NICHD算法均使较少的暴露于母体绒毛膜羊膜炎的足月新生儿暴露于抗生素,但两者在需要抗生素的新生儿数量上存在差异。
- 作者认为,通气支持和较低Apgar评分与更高的抗生素使用概率相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Maternal chorioamnionitis (MC) is one of the major risk factors for early-onset neonatal sepsis. Kaiser sepsis risk calculator (SRC) is a validated risk assessment tool for such newborns. The National Institute of Child Health and Human Development (NICHD) workshop on MC has proposed a risk assessment algorithm. The objective of the study was to compare the reduction in antibiotic use in newborns treated with SRC and NICHD algorithm and determine the antibiotic use correlation between them.
METHODOLOGY: A retrospective chart review was performed on newborns born at ≥ 37 weeks to mothers with MC during the years 2018-2020. The same cohort of newborns was evaluated using SRC and NICHD algorithm to determine whether treatment with antibiotics could have been avoided in some patients. The data were analyzed using a t-test, Chi-square test, and ANOVA.
RESULTS: During the study period, 101 newborns were born to mothers with chorioamnionitis and received antibiotics. When the newborns were assessed using the SRC, only 16/101 (15.84%) would have received treatment. When NICHD algorithm was applied to the same cohort 71/101 (70.30%) newborns would have received treatment. The two approaches agreed in their assessment for treatment or observation only in 44/101 (43.56%) of the cases. The NICHD treatment group had a higher incidence of chorioamnionitis as seen in placental pathology (94.37% vs. 75.00% for Kaiser, p-0.015). The SRC treatment group however had newborns with significantly lower Apgar score at 1 min (8.21 vs 6.63, p-0.006) and 5-minute (8.69 vs 8.00, p-0.019) and had significantly higher supplemental oxygen requirements at admission (62.50% vs. 21.13%, p < 0.001).
CONCLUSION: Both SRC and NICHD algorithms expose fewer newborns to antibiotics; however, they differ in the number of newborns that would require antibiotics. Ventilation assistance and lower Apgar scores were associated with higher probability of antibiotic administration.
参考来源
- Gupta A, Youssef J, Arora N, et al. Comparison of proposed National Institute of Child Health and Human Development panel recommendations with newborn sepsis risk calculator in term neonates exposed to maternal chorioamnionitis. Pediatr Neonatol. 2023. PMID: 37407418. doi:10.1016/j.pedneo.2023.02.008
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。